Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Nov 2;10:1255518. doi: 10.3389/fnut.2023.1255518

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2023 Fragoso-Medina, López Vaquera, Domínguez-Uscanga, Luna-Vital and García.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Principal component analysis of clinical trials addressing obesity-related inflammation in Medox^® (A, B) or uncharacterized (C, D) subsets. Analyses (A, C) included single anthocyanin doses as factors while (B, D) analyses did not. Colors are used to separate groups of trials discussed in the text. (A) The red group represents trials with low variance, the blue group represents trials with moderate variance, and the green and purple groups represent trials with high variance. (B) The red group represents trials with low variance, the blue group represents trials with moderate variance in (A, B), and the green group represents trials with high variance in (A, B). (C) The red group represents trials with low variance, and the blue group represents trials with high variance. (D) The red group represents trials with low variance, the blue group represents trials with positive values for PC2, the green group represents trials with negative values for PC1 or PC2, and the purple group represents trials with positive values for PC1.